Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs Network
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- IRCCS Policlinico S. Donato
- Enrollment
- 1000
- Locations
- 6
- Primary Endpoint
- incidence of HFpEF
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
The evolving definitions of HF, the increasing attention of the medical community, and the aging of the population are some of the factors contributing to a still debated incidence and prevalence of HFpEF across the general and specific populations. Despite the current decline in new HF cases, HFpEF shows stable incidence according to epidemiological studies. Cardiovascular risk factors, such as a long history of hypertension, diabetes, obesity, and others seem to be associated with a higher HFpEFincidence. Nevertheless, the potential echocardiographic predictors of HFpEF have not been defined yet.
Hypothesis In a population at high risk for HFpEF, collected using a multicenter echo-lab network, the real incidence of HFpEF cases and echocardiographic predictors can be identified.
Aim 1: to define the incidence of HFpEF in a high-risk cohort of patients afferent to the Italian echo-lab network.
Aim 2: to explore the standard (2D and Doppler data) and advanced (LV and LA strain) echocardiographic parameters associated with and potential predictors of HFpEF.
Methods This is a multicenter, prospective, observational study involving an Italian echo labs network. According to inclusion and exclusion criteria, patients will be enrolled during standard echocardiographic evaluation. After signing informed consent, clinical and echocardiographic data will be collected. Thereafter, they will be followed up for major clinical events (cardiovascular death, HF requiring hospitalization, myocardial infarct, and atrial fibrillation) for a period of 12 months
Investigators
Francesco Bandera
Principal Investigator
IRCCS Policlinico S. Donato
Eligibility Criteria
Inclusion Criteria
- •Age \>65 years
- •Echocardiographic LV EF \>50%
- •Diastolic dysfunction at echocardiography of at least grade 1
- •LV hypertrophy defined as: linear LV mass \>115 in men, \>95 g/m2 in women
- •Left atrium (LA) enlargement defined as LA volume \> 34 mL/ m2
Exclusion Criteria
- •Severe chronic renal failure (GFR \<15)
- •Severe chronic obstructive pulmonary disease (COPD) (FEV1 \<1)
- •More than moderate valve disease
- •Previous cardiac surgery
- •Previous LV EF \<40%
Outcomes
Primary Outcomes
incidence of HFpEF
Time Frame: after 12 months from baseline
to define the incidence of HFpEF in a high-risk cohort of patients afferent to Italian echo-lab network
Secondary Outcomes
- predictors of HFpEF(after 12 months)